| Effect of chelating ligands on Ni–Mo impregnation over wide-pore ZrO2–TiO2 J Escobar, MC Barrera, JA De los Reyes, JA Toledo, V Santes, JA Colín Journal of molecular catalysis A: Chemical 287 (1-2), 33-40, 2008 | 103 | 2008 |
| Inspiratory and expiratory muscle training in subacute stroke: a randomized clinical trial M Messaggi-Sartor, A Guillen-Solà, M Depolo, E Duarte, DA Rodríguez, ... Neurology 85 (7), 564-572, 2015 | 99 | 2015 |
| Highly active MoS2 on wide-pore ZrO2–TiO2 mixed oxides MC Barrera, M Viniegra, J Escobar, M Vrinat, JA De Los Reyes, F Murrieta, ... Catalysis today 98 (1-2), 131-139, 2004 | 82 | 2004 |
| Effect of ethyleneglycol addition on the properties of P-doped NiMo/Al2O3 HDS catalysts: Part I. Materials preparation and characterization J Escobar, MC Barrera, JA Toledo, MA Cortés-Jácome, ... Applied Catalysis B: Environmental 88 (3-4), 564-575, 2009 | 75 | 2009 |
| Highly active CoMoS phase on titania nanotubes as new hydrodesulfurization catalysts JA Toledo-Antonio, MA Cortés-Jácome, C Angeles-Chávez, J Escobar, ... Applied Catalysis B: Environmental 90 (1-2), 213-223, 2009 | 70 | 2009 |
| Benzothiophene hydrodesulfurization over NiMo/alumina catalysts modified by citric acid. Effect of addition stage of organic modifier J Escobar, MC Barrera, AW Gutiérrez, JE Terrazas Fuel Processing Technology 156, 33-42, 2017 | 63 | 2017 |
| TPX-0131, a potent CNS-penetrant, next-generation inhibitor of wild-type ALK and ALK-resistant mutations BW Murray, D Zhai, W Deng, X Zhang, J Ung, V Nguyen, H Zhang, ... Molecular cancer therapeutics 20 (9), 1499-1507, 2021 | 60 | 2021 |
| Highly dispersed uniformly sized Pt nanoparticles on mesoporous Al-SBA-15 by solid state impregnation AK Medina-Mendoza, MA Cortés-Jácome, JA Toledo-Antonio, ... Applied Catalysis B: Environmental 106 (1-2), 14-25, 2011 | 53 | 2011 |
| Highly active P-doped sulfided NiMo/alumina HDS catalysts from Mo-blue by using saccharose as reducing agents precursor J Escobar, MC Barrera, AW Gutiérrez, MA Cortés-Jacome, ... Applied Catalysis B: Environmental 237, 708-720, 2018 | 52 | 2018 |
| Effect of solvo-thermal treatment temperature on the properties of sol–gel ZrO2–TiO2 mixed oxides as HDS catalyst supports MC Barrera, J Escobar, JA de los Reyes, MA Cortés, M Viniegra, ... Catalysis Today 116 (4), 498-504, 2006 | 43 | 2006 |
| Targeting oncogene mRNA translation in B-cell malignancies with eFT226, a potent and selective inhibitor of eIF4A PA Thompson, B Eam, NP Young, S Fish, J Chen, M Barrera, H Howard, ... Molecular Cancer Therapeutics 20 (1), 26-36, 2021 | 38 | 2021 |
| Naphthalene hydrogenation over Mg-doped Pt/Al2O3 J Escobar, MC Barrera, V Santes, JE Terrazas Catalysis Today 296, 197-204, 2017 | 34 | 2017 |
| Cyclohexane Dehydrogenation over Wet-Impregnated Ni on Al2O3−TiO2 Sol−Gel Oxides J Escobar, JA De Los Reyes, T Viveros, MC Barrera Industrial & engineering chemistry research 45 (16), 5693-5700, 2006 | 32 | 2006 |
| Human-animal trust as an analog for human-robot trust: A review of current evidence DR Billings, KE Schaefer, JY Chen, V Kocsis, M Barrera, J Cook, M Ferrer, ... Army Research Laboratory, 1-28, 2012 | 30 | 2012 |
| Effect of Mo and Co loading in HDS catalysts supported on solvo-thermally treated ZrO2–TiO2 mixed oxides J Escobar, MC Barrera, A José, MA Cortés, V Santes, E Gómez, ... Catalysis today 133, 282-291, 2008 | 30 | 2008 |
| TPX-0131: A next generation macrocyclic ALK inhibitor that overcomes ALK resistant mutations refractory to current approved ALK inhibitors JJ Cui, E Rogers, D Zhai, W Deng, J Ung, V Nguyen Cancer Res 80 (16 Suppl), 5226, 2020 | 24 | 2020 |
| NiMo/alumina hydrodesulphurization catalyst modified by saccharose: Effect of addition stage of organic modifier J Escobar, AW Gutiérrez, MC Barrera, JA Colín The Canadian Journal of Chemical Engineering 94 (1), 66-74, 2016 | 23 | 2016 |
| Imported cases of malaria admitted to two hospitals of Margarita Island, Venezuela, 1998–2005 AJ Rodriguez-Morales, MV Ferrer, MA Barrera, M Pacheco, V Daza, ... Travel Medicine and Infectious Disease 7 (1), 44-48, 2009 | 22 | 2009 |
| Zotatifin, an eIF4A-selective inhibitor, blocks tumor growth in receptor tyrosine kinase driven tumors A Gerson-Gurwitz, NP Young, VK Goel, B Eam, CR Stumpf, J Chen, ... Frontiers in Oncology 11, 766298, 2021 | 20 | 2021 |
| Preclinical evaluation of eFT226, a novel, potent and selective eIF4A inhibitor with anti-tumor activity in B-cell malignancies PA Thompson, B Eam, NP Young, S Fish, J Chen, M Barrera, H Howard, ... Blood 130 (Supplement 1), 1530-1530, 2017 | 18 | 2017 |
Jose Escobar AguilarIMPDirección de correo verificada de imp.mx
